The AIDS epidemic can be ended with current drugs—in theory. Now, a rural village in impoverished Zimbabwe has figured out how to help end it in real life in a simple, low-tech way.
Efforts to treat Huntington’s disease involve costly drugs way beyond the reach of the poor communities in South America who take part in research studies
Pulitzer Center grantee Roger Thurow's new book, "The First 1,000 Days: A Crucial Time for Mothers and Children-And the World."
Filmmaker Rob Tinworth launches The Life Equation Interactive at the 2016 CUGH Conference.
Grantee Carina Storrs tells Ikonokast's Mike Haubrich why vaccines don't always work in developing countries.
Boosting the performance of the rotavirus vaccine in low-income countries is a pressing public health problem. A team of researchers are attacking it from several angles.
Liberia's Ebola survivors are still suffering. A new study hints at hidden virus remnants or immune system overreactions.
The rotavirus vaccine is now included in routine immunization in many countries around the world. But can researchers find ways to boost its performance to save more lives in low-income countries?
When the outbreak hit West Africa, fevers spiked—and so did rates of teenage pregnancy.
Where is the balance between economic calculations that save more lives in the long-term and the individual human right to health care in the near?
Zimbabwean President Robert Mugabe strongly denounces homosexuality, which starkly contrasts the human rights agenda promoted at the meeting as key to an effective HIV/AIDS response.
HIV/AIDS is a complicated disease that's becoming simpler to understand—and conquer—now that the World Health Organization has recommended treatment for all.
Donate Now
